J.P. Morgan Equity Research SA vs UBS IBD SA

First thoughts on this decision? I guess ER would be better for HF exit ops in the long term while IBD is more suited for PE?

Would the J P Morgan name help over UBS regardless of what I wanted to do afterwards?

 

JPM has a very good sell-side ER platform, if we go by II rankings and how many resources they put into their research department (vs. something like GS where they apparently don't give a fuck about their ER franchise). On the other hand, the odds of getting a FT offer for ER post-SA are lower, they run pretty lean.

Under my tutelage, you will grow from boys to men. From men into gladiators. And from gladiators into SWANSONS.
 
Best Response

I would think your options look something like this

ER SA -> ER FT 2/3 years --> HF ER SA -> ER FT 2/3 years --> ER Forever ER SA -> ER FT 2/3 years --> B-School --> HF/PE

&

ER SA -> anything full time

IBD SA ->IBD FT 2 years --> HF/PE/B-School/Pre-Mba roles

While ER does exit to HF, the consensus is that IBD will likely still have an advantage even at most HFs.

If you can take the lifestyle, I would say IBD is always the clear choice for setting up the best exit ops and best chance at a FT offer. Just my opinion.

 
sk8247365:
I would think your options look something like this

ER SA -> ER FT 2/3 years --> HF ER SA -> ER FT 2/3 years --> ER Forever ER SA -> ER FT 2/3 years --> B-School --> HF/PE

&

ER SA -> anything full time

IBD SA ->IBD FT 2 years --> HF/PE/B-School/Pre-Mba roles

While ER does exit to HF, the consensus is that IBD will likely still have an advantage even at most HFs.

If you can take the lifestyle, I would say IBD is always the clear choice for setting up the best exit ops and best chance at a FT offer. Just my opinion.

I like that breakdown.

Under my tutelage, you will grow from boys to men. From men into gladiators. And from gladiators into SWANSONS.
 

Earum aut modi qui architecto consequatur et. Reiciendis ut neque est saepe.

Mollitia fuga doloremque omnis ullam. A sint nesciunt corporis quia molestiae et eveniet. Sapiente omnis quia harum velit. Deserunt sint facilis ducimus aliquam. Sit fugit dolor et illo.

Career Advancement Opportunities

May 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 04 97.1%

Overall Employee Satisfaction

May 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

May 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

May 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (88) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (67) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Secyh62's picture
Secyh62
99.0
4
Betsy Massar's picture
Betsy Massar
99.0
5
GameTheory's picture
GameTheory
98.9
6
dosk17's picture
dosk17
98.9
7
kanon's picture
kanon
98.9
8
CompBanker's picture
CompBanker
98.9
9
numi's picture
numi
98.8
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”